Lurasidone Quantitative, Serum or Plasma
Also known as: LURASID
Use
The Lurasidone Quantitative test, designed for the measurement of lurasidone levels in serum or plasma, is a critical tool for therapeutic drug monitoring (TDM), ensuring optimal drug therapy and promoting patient adherence. It provides valuable data for healthcare providers to adjust dosing regimens effectively, particularly in managing mental health disorders where lurasidone, marketed as Latuda, is prescribed. Monitoring drug levels helps in adjusting doses to achieve therapeutic efficacy while avoiding toxicity.
Special Instructions
Not provided.
Limitations
The Lurasidone Quantitative test is performed by a non-ARUP laboratory and its performance characteristics were determined by NMS Labs without FDA clearance or approval. Moreover, the test is subject to limitations characteristic of high-performance liquid chromatography-tandem mass spectrometry, such as potential interference from other medications or substances present in the serum or plasma, which could affect the accuracy of results. Additionally, the method requires careful handling and precise measurement conditions, which are essential for ensuring reliability and accuracy of the quantitative outcomes.
New York Approved
Methodology
Mass Spectrometry
Biomarkers
Lurasidone
Analyte
LOINC Codes
- 93437-2 - Lurasidone SerPl-mCnc
Result Turnaround Time
8-11 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.3 mL
Container
ARUP Standard Transport Tube
Collection Instructions
Separate from cells ASAP or within 2 hours of collection. Transfer to an ARUP Standard Transport Tube.
Storage Instructions
Refrigerated, also acceptable at room temperature or frozen.
Causes for Rejection
Separator tubes.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 1 month |
| Refrigerated | 1 month |
| Frozen | 15 months |
Other tests from different labs that may be relevant